Quick Answer
INSMED Inc reported Diluted EPS of $6.42 per share (loss) for fiscal year 2025.
INSMED Inc Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$6.42 | -15.3% |
| 2024 | -$5.57 | -4.3% |
| 2023 | -$5.34 | -36.6% |
| 2022 | -$3.91 | -0.8% |
| 2021 | -$3.88 | -28.9% |
| 2020 | -$3.01 | +0.0% |
| 2019 | -$3.01 | -2.0% |
| 2011 | -$2.95 | -502.0% |
| 2010 | -$0.49 | -105.3% |
| 2009 | $9.30 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.75 | -37.8% | -2.9% |
| June 30, 2025 | -$1.70 | +12.4% | -19.7% |
| March 31, 2025 | -$1.42 | -34.0% | -11.8% |
| September 30, 2024 | -$1.27 | -14.4% | +34.5% |
| June 30, 2024 | -$1.94 | -9.0% | -83.0% |
| March 31, 2024 | -$1.06 | +9.4% | +4.5% |
| September 30, 2023 | -$1.11 | -1.8% | +37.6% |
| June 30, 2023 | -$1.78 | -122.5% | -52.1% |
- INSMED Inc showed a decrease of -15.3% in Diluted EPS compared to the prior fiscal year.
- Over the 2009–2025 period, INSMED Inc’s diluted eps has declined by 169.0% (from $9.30 per share to $6.42 per share (loss)).
- The most recent figure is from INSMED Inc’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: